Copy into your RSS Reader
Copy into your Podcast App
It's a good start when experimental compounds stop the proliferation of cancer cells in the lab. But, as many researchers have learned the hard way, that's just an early step toward creating a worthwhile treatment.
February 19, 2015 The Food and Drug Administration has approved a drug that thwarts some enzymes breast cancer cells use to evade treatment with estrogen-blocking drugs.
<iframe src="http://www.npr.org/player/embed/386096296/387554286" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
For now, Pfizer's world headquarters remains in New York. But a deal for AstraZeneca could turn Pfizer British.
April 28, 2014 Pfizer, founded in Brooklyn, N.Y., in 1849, would become a British company by combining with AstraZeneca. The new company would get a much lower tax rate by moving its legal headquarters overseas.
If you're interested in buying Viagra, Pfizer, the drug's maker, will now sell it to you from its official website.
May 6, 2013 Men still need a prescription for the diamond-shaped blue pills. But instead of going to the pharmacy in person, or taking their chances buying from an online pharmacy of unknown repute, men will be able to buy Viagra from the maker of the drug itself and have it shipped to their homes.
November 7, 2012 Xeljanz, a new rheumatoid arthritis drug, is the first one that works by blocking enzymes called janus kinases. They play a communication role inside the body and are involved in inflammation associated with rheumatoid arthritis.
A PET scan of the brain of a person with Alzheimer's disease.
U.S. National Institute on Aging/via Wikimedia Commons
August 7, 2012 Pfizer's research on an experimental drug that attacks plaques in the brain has been discontinued. But scientists say they're hopeful that new treatments that attack a specific protein in plaques will have better success.
Pfizer will drop or qualify some health claims on labels and in ads for Centrum vitamins and supplements.
July 6, 2012 Under an agreement between the drugmaker and the Center for Science in the Public Interest, Pfizer won't make claims about "breast health" or "colon health" for Centrum products. In return, the consumer group agreed not to take legal action.
February 1, 2012 Pfizer is recalling 1 million packages of oral contraceptives because of errors in the order or types of pills. The mistakes could leave women at risk for unintended pregnancy.
After 14 years, the cholesterol-lowering drug Lipitor is going generic.
December 1, 2011 Two new generic brands of cholesterol-lowering medication threaten sales to Pfizer's number one selling drug — Lipitor. Good news? More people can afford it now.
NPR thanks our sponsors
Become an NPR sponsor